Overview

Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The malaria parasite Plasmodium falciparum remains at sub-patent level throughout the dry season in areas of seasonal malaria transmission. Targeting this parasite reservoir before the transmission season could be a good strategy for malaria control. We are conducting a randomized double blind placebo controlled mass drug administration trial in eight village to clear the dry season low level parasitaemia with an ultimate aim of controlling malaria in eastern Sudan.
Phase:
Phase 3
Details
Lead Sponsor:
Tropical Medicine Research Institute
Collaborators:
International Atomic Energy Agency
London School of Hygiene and Tropical Medicine
Treatments:
Artesunate
Pyrimethamine
Sulfadoxine